Zoetis Inc. (LON:0M3Q)
London · Delayed Price · Currency is GBP · Price in USD 122.23
-0.33 (-0.27%)
At close: Jan 30, 2026
Zoetis Market Cap
Zoetis has a market cap or net worth of 40.1 billion as of January 30, 2026. Its market cap has decreased by -34.94% in one year.
Market Cap
40.10B
Enterprise Value
43.89B
Revenue
6.99B
Ranking
n/a
PE Ratio
20.33
Stock Price
122.23
Market Cap Chart
Since February 1, 2013, Zoetis's market cap has increased from 9.85B to 40.10B, an increase of 307.01%. That is a compound annual growth rate of 11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 40.10B | -2.68% |
| Dec 31, 2025 | 41.20B | -29.84% |
| Dec 31, 2024 | 58.72B | -17.46% |
| Dec 29, 2023 | 71.14B | 25.49% |
| Dec 30, 2022 | 56.69B | -33.52% |
| Dec 31, 2021 | 85.27B | 48.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |